Chordate Medical Holding AB (FRA:K1Z) Operating Cash Flow per Share : €-3.15 (TTM As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Chordate Medical Holding AB Operating Cash Flow per Share?

Chordate Medical Holding AB's operating cash flow per share for the three months ended in Sep. 2024 was €-0.62. Chordate Medical Holding AB's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2024 was €-3.15.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 21.60% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 49.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Chordate Medical Holding AB's Operating Cash Flow per Share or its related term are showing as below:

FRA:K1Z' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -684.5 Med: 28.35 Max: 94.2
Current: 21.6

During the past 9 years, Chordate Medical Holding AB's highest 3-Year average Operating Cash Flow per Share Growth Rate was 94.20% per year. The lowest was -684.50% per year. And the median was 28.35% per year.

FRA:K1Z's 3-Year OCF Growth Rate is ranked better than
74.89% of 685 companies
in the Medical Devices & Instruments industry
Industry Median: 3.3 vs FRA:K1Z: 21.60

Chordate Medical Holding AB Operating Cash Flow per Share Historical Data

The historical data trend for Chordate Medical Holding AB's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordate Medical Holding AB Operating Cash Flow per Share Chart

Chordate Medical Holding AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-21.28

-9.41

-0.01

-5.56

-4.12

Chordate Medical Holding AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.90	-1.10	-0.80	-0.64	-0.62

Competitive Comparison of Chordate Medical Holding AB's Operating Cash Flow per Share

For the Medical Devices subindustry, Chordate Medical Holding AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chordate Medical Holding AB's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Chordate Medical Holding AB's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Chordate Medical Holding AB's Price-to-Operating-Cash-Flow falls into.

Chordate Medical Holding AB Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Chordate Medical Holding AB's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-2.437	/	0.591
	=	-4.12

Chordate Medical Holding AB's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Sep. 2024 )	=	Cash Flow from Operations (Q: Sep. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Sep. 2024 )
	=	-0.603	/	0.980
	=	-0.62

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3.15

Chordate Medical Holding AB Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Chordate Medical Holding AB's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Chordate Medical Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chordate Medical Holding AB (FRA:K1Z) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

CMH:Sweden

Address

c/o Regus, Kistagangen 20B, Kista, SWE, 164 40

Website

https://www.chordate.com

Chordate Medical Holding AB is a medical technology company that has developed patented and CE-marked a new nerve-modulating treatment technology for chronic nasal congestion and chronic migraine. The company sells its products in Selected European markets, Israel, and Saudi Arabia. The company's product range is based on the CE-marked treatment units Chordate System S100 and S120 for rhinitis and S220 for migraine, registered for the indications of preventive treatment of chronic migraine and chronic rhinitis and use on patients. The company sells its product system, including treatments, through distributors to clinics and hospitals in its primary markets.

Chordate Medical Holding AB Headlines

No Headlines